Browse the evidence

Cortical brain responses to sustained attention tasks decrease significantly with accrued sleep debt, whereas subcortical responses are primarily modulated by circadian rhythmicity and remain largely unaffected by sleep pressure.

If you are sleep-deprived, your brain's ability to sustain attention degrades specifically in cortical areas responsible for higher-order processing. This is not just 'feeling tired'; it is a measurable physiological change. To maintain performance, you must respect the circadian rhythm (melatonin timing) and avoid extending wakefulness into the biological night, as sleep debt will disproportionately impair cortical function.

Dietary restriction (DR) extends lifespan by triggering mitochondrial adaptations, including increased sirtuin activity and mitochondrial biogenesis via PGC-1α.

Consider dietary restriction as a primary strategy for longevity. It works by activating sirtuins and boosting mitochondrial biogenesis (via PGC-1α). While the exact dose isn't defined here, the mechanism suggests that reducing caloric intake triggers protective mitochondrial adaptations.

Dietary restriction of specific amino acids, particularly methionine or general protein, inhibits mTORC1 signaling and extends rodent lifespan, offering a sustainable alternative to pharmacological mTOR inhibition.

Consider reducing overall protein intake or specifically restricting methionine (found in high amounts in meat, eggs, and some nuts) to potentially slow aging via mTORC1 inhibition. This can be achieved through plant-based diets which are often lower in methionine. This approach is safer and more sustainable than long-term pharmacological rapamycin use, though it requires careful planning to ensure adequate nutrition.

Long-term DHEA replacement (50 mg/day) improves psychological well-being (specifically the 'role emotional' dimension of SF-36) in patients with primary adrenal insufficiency, but does not significantly improve fatigue, cognitive function, or sexual function.

For people with Addison's disease, DHEA might help with emotional well-being and feeling like you can handle daily roles, but don't expect it to fix fatigue or memory problems. It's a targeted treatment for a specific hormonal lack.

Obesity is associated with a specific gut microbiota composition characterized by a higher Firmicutes-to-Bacteroidetes ratio, lower bacterial gene richness, and increased gut permeability leading to metabolic endotoxemia.

Obesity is linked to a less diverse gut microbiome with specific bacterial imbalances. While you cannot directly 'buy' a healthy microbiome, eating a diverse, fiber-rich diet supports the bacteria that help regulate energy and inflammation.

Higher personal economic status is associated with specific gut microbiota shifts (increased Bacteroides, decreased Prevotella) that do not necessarily correlate with increased metabolic syndrome risk, indicating that economic status alone does not predict dysbiosis.

Do not assume that moving to a higher economic bracket automatically worsens your gut health. This study shows that higher income was associated with a microbiome profile that was *not* more dysbiotic. Focus on maintaining physical activity to prevent MetS, as diet quality may actually improve with income.

Obesity is a risk factor for several cancers, including colon, pancreas, kidney, prostate, breast, and endometrium, potentially through mechanisms involving chronic inflammation, insulin resistance, and adipocytokine production.

Keeping a healthy weight can help reduce the risk of several types of cancer. This is achieved through a combination of healthy eating, regular physical activity, and maintaining a healthy body composition.

Leptin and estrogen signaling modulate the skeleton's sensitivity to mechanical loading, with leptin deficiency requiring higher body weight to achieve equivalent bone mass.

Hormonal health, particularly leptin and estrogen levels, influences how effectively your bones respond to body weight. Hormonal imbalances can decouple the protective effect of weight on bones, meaning weight management alone may not be sufficient for bone health in all individuals.

Disuse atrophy involves complex, fiber-type-specific interactions between myonuclear domain maintenance, satellite cell (SC) dynamics, and molecular signaling pathways (MAFbx/MuRF1, IGF1-AKT-mTOR, Myostatin), where previous hypertrophy may protect against myonuclear loss.

Disuse atrophy is not a simple loss of muscle mass but a complex cellular response involving myonuclei, satellite cells, and signaling pathways. Previous muscle growth (hypertrophy) may protect against some aspects of atrophy, such as myonuclear loss. Recovery requires re-applying mechanical load, and nutrient supplementation (e.g., amino acids) may enhance this. The response varies by fiber type and the severity/duration of disuse.

Vitamin D3 supplementation (2500 IU/day) does not improve cardiovascular risk markers (endothelial function, arterial stiffness, or inflammation) in post-menopausal women, regardless of baseline vitamin D status.

If you are a post-menopausal woman taking Vitamin D for heart health, this study suggests it likely won't improve your artery stiffness or blood vessel function, even if it successfully raises your blood Vitamin D levels. Continue taking it if recommended for bone health, but do not rely on it as a strategy to prevent cardiovascular disease.

Continuous positive airway pressure (CPAP) therapy reverses oxidative stress and improves endothelial function in patients with obstructive sleep apnea (OSA).

If you have OSA, using CPAP therapy nightly is the most effective way to protect your heart and blood vessels by reversing the oxidative stress caused by breathing pauses. While it can be uncomfortable at first, it is superior to antioxidant supplements for treating the root cause.

Obstructive sleep apnea (OSA) causes oxidative stress through intermittent hypoxia, leading to endothelial dysfunction and increased cardiovascular disease risk.

Untreated OSA creates a cycle of oxygen deprivation that damages blood vessels through oxidative stress, increasing the risk of hypertension and heart disease. Treating OSA is crucial for long-term cardiovascular health.

Slow-wave sleep (SWS) episodes are temporally associated with a significant decrease in plasma cortisol levels, suggesting an inhibitory relationship or synchronized regulation between deep sleep and adrenocortical quiescence.

Prioritize slow-wave sleep (deep sleep) to help regulate cortisol levels. This study shows that deep sleep phases are strongly linked to drops in cortisol. If you are struggling with high stress or cortisol-related issues, focusing on sleep hygiene to maximize deep sleep duration may be as effective as other stress-management techniques.

Myostatin induces reactive oxygen species (ROS) production in skeletal muscle cells via a feed-forward loop involving NF-κB activation, TNF-α upregulation, and NADPH oxidase (Nox1) expression, leading to muscle wasting.

This research highlights a biological mechanism where the protein myostatin triggers oxidative stress and inflammation in muscle, leading to muscle loss. While this is a natural process in aging or disease, it suggests that targeting the inflammatory pathway (NF-κB/TNF-α) might help preserve muscle mass, rather than just focusing on exercise or nutrition alone.

Musclin, an exercise-stimulated myokine, enhances physical endurance and aerobic capacity by potentiating ANP signaling to increase cGMP, thereby promoting PGC1-α-dependent mitochondrial biogenesis in skeletal muscle.

This research identifies musclin as a key messenger released by muscles during exercise that helps build mitochondria, the energy powerhouses of cells. While musclin itself is not currently available as a therapeutic, the findings reinforce that physical activity triggers specific hormonal responses that improve endurance. To boost this pathway, engage in regular aerobic exercise, which naturally stimulates musclin production and subsequent mitochondrial biogenesis.

Long-term instability of the intestinal microbiome is significantly associated with metabolic liver disease (FLD) and diabetes mellitus, characterized by an increase in facultative pathogens like Enterobacteriaceae and Escherichia/Shigella.

If you have metabolic liver disease or diabetes, your gut microbiome is likely less stable and may harbor more opportunistic pathogens. This instability is a marker of metabolic health rather than just a random fluctuation. Managing metabolic health may be key to maintaining microbiome stability.

High initial alpha diversity, female sex, high household income, and preserved exocrine pancreatic function are associated with the greatest stability of the faecal microbiota over a 5-year period.

Maintaining high microbial diversity and pancreatic health may help keep your gut microbiome stable. While you cannot change your sex or income, focusing on metabolic health and avoiding factors that reduce diversity (like unnecessary antibiotics) may support stability.

Microbiota instability and metabolic diseases like FLD and diabetes are linked to an increased predicted microbial potential for lipopolysaccharide (LPS) biosynthesis, which may trigger proinflammatory cytokines and aggravate metabolic disorders.

An unstable gut microbiome in the context of metabolic disease may lead to higher levels of bacterial components (LPS) that trigger inflammation. This suggests that managing gut health could potentially reduce inflammatory burden in metabolic disorders.

Calcium supplementation (≥1,000 mg/day) increases the risk of cardiovascular events, including myocardial infarction and coronary heart disease, particularly in men and postmenopausal women.

If you are taking calcium supplements, especially doses over 1,000 mg per day, be aware that this may increase your risk of heart disease, particularly if you are a man or postmenopausal woman. Prioritize dietary calcium sources, which do not appear to carry this risk, and consult your doctor about your specific cardiovascular risk profile before continuing high-dose supplementation.

Bariatric surgery effectively treats obesity by reducing stomach volume and nutrient absorption, and inducing faster satiety.

For severely obese individuals, bariatric surgery is a viable option that mechanically restricts food intake and alters satiety signals. It is typically reserved for cases where lifestyle changes have not been sufficient.

Peripheral hormones (leptin, insulin, ghrelin, PYY, GLP-1, CCK) regulate appetite and energy balance by acting on the hypothalamus and brainstem, with resistance to these hormones contributing to obesity.

Understand that hormones like leptin and insulin play a crucial role in hunger and satiety. In obesity, these hormones may become resistant, making it harder to regulate appetite. Medical treatments targeting these hormones (like GLP-1 agonists) may be effective.

Short-term (5-week) exercise interventions, whether HIIT or MVCT, significantly reduce serum testosterone and estradiol levels in obese young women, but do not significantly alter blood lipid profiles (TC, LDL, TG, HDL).

If you are an obese young woman, 5 weeks of exercise (HIIT or continuous) will likely lower your sex hormones (testosterone and estradiol), which may help with hormonal balance. However, do not expect your cholesterol or triglycerides to improve in just 5 weeks; you likely need to exercise for longer or burn more total calories per week to see changes in blood lipids.

Use of specific antiretroviral medications, particularly lopinavir/ritonavir and didanosine (ddI), significantly increases the risk of developing metabolic syndrome in HIV-infected adults, independent of general inflammation markers.

If you are HIV-positive, your medication choice matters for your metabolic health. Drugs like Kaletra (lopinavir/ritonavir) and didanosine are linked to a higher risk of metabolic syndrome. Discuss lipid management and body composition with your provider, but do not stop your medication without medical advice, as uncontrolled viral load is also a major risk factor.

Increasing viral load (specifically a >= 0.5-log increase) and higher trunk-to-limb fat ratio are significant independent predictors of metabolic syndrome incidence in HIV-infected adults, regardless of BMI adjustments.

Your metabolic health is closely tied to how well your HIV is controlled and where your body stores fat. Keeping your viral load low and monitoring your body composition (specifically trunk fat) are critical. If you notice changes in your body shape or your viral load rises, talk to your doctor about adjusting your treatment or managing your lipids.